Meeks Blocks $2.8B Bomb Sale to Israel Over Civilian Safety Concerns

Key points

• Rep. Gregory Meeks, ranking member of the House Foreign Affairs Committee, refused to clear a $2.8 billion arms package for Israel.
• The sale includes 20,000 MK-84 bombs, 20,000 BLU-117 bombs, and 20,000 I-2000 penetrator warheads, funded through Foreign Military Financing.
• Meeks stated the administration failed to provide assurances that the weapons would be used in accordance with US law and with civilian protections.
• The informal 'tiered review' process allows Meeks to delay the sale, but blocking it entirely requires a veto-proof joint resolution from Congress.
• The Trump administration has already expedited over $12 billion in arms sales to Israel since taking office, including a $6.67 billion package in January.

Background

This development follows a series of US arms transfers to Israel since 2024, including a pause by the Biden administration that was reversed by the Trump administration. Previous coverage highlighted bipartisan concerns over civilian harm in Gaza and the rapid pace of weapons transfers, with earlier reports noting potential violations of international humanitarian law and Leahy laws.

How outlets are covering it

The Guardian and AP News emphasize the scale of the sale and the administration's use of emergency declarations to bypass oversight, noting that Secretary of State Marco Rubio previously fast-tracked similar deals. J Street, a liberal pro-Israel group, criticized the sale in a statement to Haaretz, arguing that such weapons hinder rebuilding efforts in Gaza. Meeks, while maintaining strong pro-Israel views, framed the hold as a necessary oversight measure to ensure lawful use of US-funded weapons, distinguishing his action from a rejection of Israel's defense needs. The state department did not immediately respond to requests for comment.

Why it matters

The hold highlights growing tensions within the US Congress over the pace and oversight of arms sales to Israel, particularly amid international concerns over civilian casualties in Gaza. It underscores the limits of informal congressional review and the administration's ability to bypass legislative checks through emergency declarations, potentially setting a precedent for future foreign military financing decisions.

What to watch

The administration may declare a national security emergency to bypass the informal hold and fast-track the sale, as it did in 2025. Alternatively, Congress could attempt to pass a veto-proof joint resolution of disapproval, though such a measure failed along party lines in April. The state department may also provide additional assurances to address Meeks's concerns, potentially clearing the path for the sale.